Spect ct -dan berman
-
Upload
society-for-heart-attack-prevention-and-eradication -
Category
Health & Medicine
-
view
43 -
download
0
Transcript of Spect ct -dan berman
![Page 1: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/1.jpg)
SPECT/CT for Atherosclerosis Imaging: The Future is Clear
Daniel S. Berman, MDDirector, Cardiac Imaging
Cedars-Sinai Medical Center
Professor of MedicineDavid Geffen School of Medicine at UCLA
![Page 2: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/2.jpg)
DISCLOSUREDaniel S. Berman, M.D.
declares the following relationships:
Grant Support: BMS Medical Imaging, Astellas, GE Amersham, Mallinckrodt-Tyco Speakers Bureau: Astellas Consultant: Mallinckrodt-Tyco
Spectrum Dynamics Royalties: Cedars-Sinai Medical Center Stockholder: Spectrum Dynamics
![Page 3: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/3.jpg)
MDCT Technical Parameters 2005
Four major manufacturers with 64 slice CT
• ~.4-.5 mm3 isotropic voxels
• Temporal resolution: 165-210 ms for 180 (330-420 ms rotation time)
• Cardiac study in 5-10 beats
![Page 4: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/4.jpg)
76 M #3311-1526
Sx: ASYMPTOMATICRISK FACTORS: CHOLESTEROLRESTING ECG: NORMAL
RESULTS OF EXERCISE:DURATION: 9:39HR: 131 (91% MPHR) BP: 134/74 150/72CLINICAL RESPONSE: NONISCHEMICECG RESPONSE: NONISCHEMIC
![Page 5: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/5.jpg)
73 M #3311-1526EBT RESULTS
Location # Calcified Lesions
Calcified Plaque Volume (mm3)
Calcium Score
LAD 3 97 126
* 32th percentile
![Page 6: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/6.jpg)
76 M #3311-1526CTA
![Page 7: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/7.jpg)
76 M 11/3/05 #3311-1526Stress MIBI
Rest Tl
Stress MIBI
Rest Tl
Stress MIBI
Rest Tl
Stress MIBI
Rest Tl
![Page 8: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/8.jpg)
76 M #3311-1526
![Page 9: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/9.jpg)
A B C D
Calcification Soft Plaque
D2
Lesion
76 M #3311-1526
![Page 10: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/10.jpg)
Limitations of Anatomic Imaging Little information regarding disease activity
• Two patients: with mild coronary calcium, score ~100 discovered on screening 1 yr ago and placed on statin, ASA, and ACE
• Patient A: recently symptomatic• Patient B: still asymptomatic• Both undergo CT coronary angiography, and
are found to have 75% mid LAD stenosis by CT angio AND extensive non-calcified plaque by IVUS
• Should the treatment be the same?
![Page 11: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/11.jpg)
It will be!
![Page 12: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/12.jpg)
Why not catheterize all suspected CAD patients?
Occulo-stenotic reflex*: unnecessary PCI• Immediate Risk – Death (rare)– Clinical MI (uncommon)– Subclinical MI (more frequent)– Branch occlusion (frequent)
• Late risk– Possible higher mortality risk than medical therapy in patients without ischemia
• Costs
• Objective measurements of perfusion and function• Accurate for assessing risk of cardiac death (CD)• Relationship of degree of abnormality to risk• Identifies likely to benefit from revascularization• Proven as cost effective “gatekeeper” to the cath labLimitations• Cannot detect early atherosclerosis• May underestimate extent of CAD
*Topol
![Page 13: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/13.jpg)
Cardiac CT
Limitations• Densely calcified plaques: nondiagnostic• Dependence on low HR and regular rhythm• Radiation, iodinated contrast• Overestimation of stenosis• No information regarding plaque “activity”
![Page 14: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/14.jpg)
• No Hx CAD• Known CAD • Post-PTCA• Post-CABG • Men and Women• Sx and Asx • DM• Elderly
SPECT: Risk Increases as a Function of Stress Perfusion Abnormality
Extent/Severity of Perfusion Defects
Ris
k*
*Adjusted or unadjusted
Guidelines for Clinical Use of Cardiac Radionuclide Imaging 2003
Data from over 50,000 patients
![Page 15: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/15.jpg)
log
Haz
ard
Rat
io0
12
34
56
% Myocardium Ischemic0 12.5% 25% 32.5% 50%
Medical Rx
Revasc*
*
*p<0.001
Adjusted† Risk of Cardiac Death vs MPS ischemiaRevascularization vs Medical Rx
Hachamovitch, et al Circulation 2003
†Adjusted for predictorsof revascularization as well asclinical, hx, stress SPECT data
![Page 16: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/16.jpg)
VISUAL SSSSTANDARDTPD
stenosis ≥ 50%
1.00.75.50.250.00
1.00
.75
.50
.25
0.00
1 - Specificity
Sens
itivi
ty
Changes in Analytic SoftwareAutomatic Total Perfusion Deficit
**
* P < 0.05
Slomka, et al J Nucl Cardiol 2005;12:66-77
![Page 17: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/17.jpg)
When was the last fundamental change in the detector technology?
Nuclear Cardiology: Single Photon Imaging
![Page 18: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/18.jpg)
When was the last fundamental change in the detector technology? 1958: Hal Anger patented the current NaI (Tl) detector/photomultiplier array configuration (#3011057)
Nuclear Cardiology: Single Photon Imaging
![Page 19: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/19.jpg)
Resolution & Contrast - a Comparison
Total counts: 2,500K Total counts: 2,500K
Spectrum-Dynamics
Coronal
Sagittal
Transverse
Net acquisition time: 9 minutesFrame angle: 3°, positions:60, 9sec per position
Net acquisition time: 1 minutepositions:40, 1.5sec per position
Millennium VG a
Spectrum Dynamics Measured Contrast
Target A: 1.6
Target B: 2.2
Millenium Measured Contrast
Target A: unseen
Target B:1.3
3:12:1
![Page 20: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/20.jpg)
Cardiac Phantom
Conventional• No AC• Acquisition time 12.5 m
Spectrum Dynamics• No AC• Acquisition time 1.25 m
•Tc99m
•Heart : .5mCi•Background : 2mCi (.19mCi/l)•Liver : .23mCi (.19mCi/liter)
![Page 21: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/21.jpg)
Cardiac SPECT ImprovementsImplications for CHD and Atherosclerosis Testing
• Increased sensitivity: reduced acquisition time – Dynamic cardiac SPECT:
• time-activity curves for blood and myocardium• Compartment modeling results in:
– Absolute blood flow (voxel)– Coronary Flow Reserve: a region compared to itself– Coronary endothelial function (CPT)
• Increased resolution:– Potential to directly image plaque
• quantify “activity” of atherosclerosis
![Page 22: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/22.jpg)
SPECT/CT
Philips Precedence Siemens Simbia
![Page 23: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/23.jpg)
Dynamic SPECT for Molecular Imaging
• Noninvasive biopsy• Specific diagnosis
CT for Structure
DynaQ™ hybrid scanner
![Page 24: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/24.jpg)
Who needs PET/CT or SPECT/CT
• Equivocal nuclear• Follow-up studies after initial CT (or
nuclear)• Why simultaneous: molecular imaging
![Page 25: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/25.jpg)
Comparative Spatial Resolution and Tracer Concentration
SPECT PET ECHO MRI CT
Resolution (mm)
7-15 3-10 < 1 < 1 < 1
Tracer Concentration
pM-nM* pM-nM* 10-100 μM
10-100 μM
10-100 μM
*picomolar-nanomolar concentrations employed are key advantage of the radionuclide methods
![Page 26: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/26.jpg)
translocasedeath domains
mediated signaling
activation of theexecutioner of apoptosis
scramblase floppase
?
binding followed by2D-crystallization
Annexin VDetection of the
apoptotic cellTNF or
Fas Ligand
TNFR orCD95 + +-
Courtesy Chris Reutlingsperger, Maastricht University
Tc-99m Annexin V: Probe for Vulnerable Plaque
![Page 27: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/27.jpg)
Old TIA Recent TIAA B
C D
Transverse
Coronal
ANT
L
AnnexinIHC inEndarterectomy
Keitselaar, Hofstra, Narula; NEJM 2004
Annexin-V Imaging For ApoptosisAnnexin-V Imaging For Apoptosis
![Page 28: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/28.jpg)
Annexin V-Tc99mautoradiograph
Digital photographdissected apoE-/- aorta
H & E
Histological AHA classificationStage IVa (vulnerable plaque)
Tc-99m Annexindissected aorta apoE -/- mouse
C. MoriStanford, 2005
![Page 29: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/29.jpg)
99mTc-Annexin V SPECT for In Vivo Detection of Atherosclerotic Lesions in Porcine Coronary Arteries
Johnson et al. J Nucl Med 2005;46:1186-93
Scan positive
Scan negative
![Page 30: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/30.jpg)
Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin
Matter et al. Circ Res 2004;95:1225-33
125I-labeled L19 to atherosclerotic plaques in ApoE-/- mice.
![Page 31: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/31.jpg)
OxLDL AB uptake reflects plaque burden
R=0.95P<0.001
0.00
0.05
0.10
0.15
0.20
0.25
0 500 1000 1500 2000Aortic weight (mg)
(%ID
)
MDA2
125I-MDA2 Uptake in Mouse and Rabbit Atherosclerotic Plaques
Tsimikas J Nucl Cardiol 1999, ATVB 2001
![Page 32: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/32.jpg)
IL2 SPECT in 2 pts with bi-lateral carotid plaques
A Annovazzi e A Signore ACC 2005
![Page 33: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/33.jpg)
IL2 SPECT: Carotid T/B ratios in patients from LS before and after 3
month treatment
1
1,5
2
2,5
3
3,5
Before therapy After therapy
99m
Tc-
IL2
upta
ke (C
/B r
atio
s)
Atorvastatin
1
1,5
2
2,5
3
3,5
Before diet After dietHypocholesterole
mic diet
![Page 34: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/34.jpg)
SPECT for imaging vulnerable plaquePotential to Image Multiple Molecular
Processes Simulaneously • Apoptosis
• IK-17
• Oxidized LDL
• Interleukin 2
• Thrombus
• Activated platelets
• Neovascularization
![Page 35: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/35.jpg)
Molecular ImagingNeeded Developments
• Discovery in molecular biology
• New probes (with FDA approval)
• Multimodality technology
– Structure/function
Post-processing software
• Reimbursement
![Page 36: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/36.jpg)
SPECT/CT for Atherosclerosis Imaging• CT: quantify plaque volume
• SPECT or PET:
– quantify plaque activity
– Potential to quantify rest/stress blood flow
Advantage of SPECT
• Multiple tracers simlutaneously
• Possible wider availability of tracers and cameras
• Potential of SPECT• Increased sensitivity and resolution need to be realized
![Page 37: Spect ct -dan berman](https://reader036.fdocuments.us/reader036/viewer/2022062523/58ee1ed91a28ab13578b4629/html5/thumbnails/37.jpg)